@FierceMedDev: Out of the mind of a Ph.D student- a new test for glucose levels using sweat, urine or tears. More | Follow @FierceMedDev
@MarkHFierce: The FDA wants a judge to dismiss a lawsuit by ex-device center employees accusing the agency of spying on them. Article | Follow @MarkHFierce
@DamianFierce: Welch Allyn touts its easy-to-use, iPhone-based eye exam device. Story | Follow @DamianFierce
> The medical device industry's business model is outmoded, and devicemakers will need to change their ways to cope with changing markets, according to a study by the Boston Consulting Group. Article
> Mass Device takes a look at how the medical device world targets its campaign contributions, and, unsurprisingly, anti-tax stalwart Sen. Orrin Hatch is the top recipient. Story
> Dutch medical device consulting firm Qserve group is expanding into Massachusetts, which houses one of the largest industry clusters in the United States. Item
> Roche Diagnostics ($RHHBY) has launched its Accu-Chek device in the U.S. The tech combines a blood glucose meter with an insulin pump via Bluetooth wireless technology. More
> Researchers are developing a disposable microchip that could enable easier diagnosis of everything from cancer to sexually transmitted infections. Story
> Rosetta Genomics and Precision Therapeutics have launched the miRview mets2 assay in the U.S. oncology market. Release
Biotech News
@FierceBiotech: J&J, Lilly and Boehringer tout data on SGLT2 drugs for diabetes. More | Follow @FierceBiotech
@JohnCFierce: BioInvent in Sweden takes out the ax again and chops 20 jobs, the survivors are focusing on cancer drugs. Release | Follow @JohnCFierce
@RyanMFierce: Sanofi/Genzyme's late-stage Gaucher pill hits goal in late-stage study, next-gen treatment for rare LSD. More | Follow @RyanMFierce
> J&J, Astellas strike potential $945M deal for oral RA drug. Story
> ArQule shares nosedive with failure of key PhIII trial for lung cancer drug. Article
Pharma News
@FiercePharma: Kaiser, Washington Post team up for look at co-pay coupons. Upshot: Good for patient, but not for payer. More | Follow @FiercePharma
> More payers than expected cover Vivus' Qsymia. Story
> Merck's Gardasil deemed safe in another large study. Report
Pharma Manufacturing News
> Drugs for illegal Internet pharmacy made in India, Mexico. Report
> China's Tianyin moves ahead with plant as profit plummets. Story
> FDA tries to teach consumers of Internet dangers. Article
Biotech Research News
> Study: Impropriety affects retracted research more than honest mistakes. Article
> New drug target could halt age-related immune system declines. Story
> UC Davis: Induced pluripotent stem cells resemble cancer cells. Report
> Avatar mice up ante for personalized drug treatment research. Item